U.S. Markets closed

  • S&P 500

    3,911.74
    +116.01 (+3.06%)
     

  • Dow 30

    31,500.68
    +823.32 (+2.68%)
     

  • Nasdaq

    11,607.62
    +375.43 (+3.34%)
     

  • Russell 2000

    1,765.74
    +54.06 (+3.16%)
     

  • Crude Oil

    107.06
    +2.79 (+2.68%)
     

  • Gold

    1,828.10
    -1.70 (-0.09%)
     

  • Silver

    21.13
    +0.09 (+0.42%)
     

  • EUR/USD

    1.0559
    +0.0034 (+0.3273%)
     

  • 10-Yr Bond

    3.1250
    +0.0570 (+1.86%)
     

  • Vix

    27.23
    -1.82 (-6.27%)
     

  • GBP/USD

    1.2270
    +0.0009 (+0.0736%)
     

  • USD/JPY

    135.1700
    +0.2370 (+0.1756%)
     

  • BTC-USD

    21,202.98
    +98.67 (+0.47%)
     

  • CMC Crypto 200

    462.12
    +8.22 (+1.81%)
     

  • FTSE 100

    7,208.81
    +188.36 (+2.68%)
     

  • Nikkei 225

    26,491.97
    +320.72 (+1.23%)
     

Merck - Ridgeback's COVID-19 Antiviral Shows Rapid Elimination Of Infectious SARS-CoV-2 Than Placebo

  • Oops!
    Something went wrong.
    Please try again later.
Vandana Singh
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • MRK
    Watchlist

  • Merck & Co Inc (NYSE: MRK) and Ridgeback Biotherapeutics will present data evaluating Lagevrio (molnupiravir), an oral COVID-19 antiviral, at the 2022 European Congress of Clinical Microbiology & Infectious Diseases.

  • The presentation includes final analyses evaluating virologic outcomes throughout and following a five-day course of molnupiravir as part of the Phase 3 MOVe-OUT trial.

  • At Day 3 of treatment, among patients with the infectious virus at baseline, infectious SARS-CoV-2 was detected in 0.0% (n=0/92) of patients who received molnupiravir, compared with 21.8% (n=20/96) of patients who received placebo.

  • At Day 5, infectious virus was detected in 0.0% (n=0/91) of patients in the molnupiravir arm compared with 2.2% (n=2/89) in the placebo arm.

  • Related: WHO Conditionally Recommends Merck's COVID-19 Antiviral Pill For High-Risk Patients.

  • At Day 10, no infectious virus was detected in either arm for patients with the contagious virus at baseline.

  • Molnupiravir is being evaluated for post-exposure prophylaxis in the MOVe-AHEAD Phase 3 study evaluating the efficacy and safety of molnupiravir in preventing the spread of COVID-19 within households.

  • Price Action: MRK shares are up 0.55% at $82.50 during the market session on the last check Friday.

See more from Benzinga

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Recommended Stories

  • Jim Cramer Says Earnings Estimate Cuts Will Form an Investable Bottom; Here Are 3 ‘Strong Buy’ Stocks That Are Already Down 50%

    As we move toward the end of Q2, it’s time to start thinking about earnings. Looking back at the quarter, analysts are predicting earnings growth of 8%, which may rise to 11% heading into next year. It’s a rosy picture, but it’s also not a sure thing. GDP contracted in Q1, by nearly 1.5%, and some estimates are showing 0% growth in Q2. Such results would meet the technical definition of a recession – and recession is hardly the usual environment to find robust earnings growth. Looking at current

  • Russia to default for first time in a century as payment deadline looms

    Nuclear submarine supplier to be sold to US buyer after diplomatic row Russian default expected within days Retail sales volumes down 0.5pc in May FTSE 100 rises strongly Ambrose Evans-Pritchard: The pro-Brussels establishment is painting Brexit as an economic disaster to reverse it Sign up here for our daily business briefing newsletter

  • How Much Does a $300,000 Annuity Pay Per Month?

    When you need another stream of income for retirement, you might consider an annuity. You purchase the annuity from an insurance company and receive payments back at a later date. Before buying an annuity, it's important to consider how much … Continue reading → The post How Much Does a $300,000 Annuity Pay Per Month? appeared first on SmartAsset Blog.

  • Musk Cites Tesla Bankruptcy Fears, Wants You to Know Something Big

    Despite bankruptcy fears, layoffs, and lawsuits, Elon Musk wants people to know about Tesla's recent American-made win.

  • 10 Value Stocks to Buy According to Billionaire David Tepper

    In this article, we will take a look at 10 value stocks to buy according to billionaire David Tepper. If you want to skip our discussion on Tepper’s history and his hedge fund’s performance, go directly to 5 Value Stocks to Buy According to Billionaire David Tepper. With a net worth of $16.7 billion, David […]

  • 8.6% inflation is turning your cash into trash — but these 3 simple income stocks (yielding as high as 12%) can help you come out ahead

    At current levels, investors need a 7% to 8% return just to preserve their wealth.

  • Meme-Stock Probe Finds Robinhood Woes Were Worse Than It Let On

    (Bloomberg) -- Robinhood Markets Inc. faced a more dire situation during the height of last year’s meme-stock frenzy than executives at the online brokerage let on publicly, according to a report from top Democrats on a key congressional committee. Most Read from BloombergSupreme Court Overturns Roe, Transforming Abortion-Rights FightStocks Roar Back With Best Week in a Month: Markets WrapJuul’s Vaping Products Are Ordered Off the Market in the US‘Coast to Coast’ Housing Correction Is Coming, Sa

  • Why Bausch Health Stock Is Bolting Higher Today

    Shares of the specialty pharmaceutical company Bausch Health Companies (NYSE: BHC) are surging today in response to the news that Joseph Papa has resigned from the board of directors effective immediately. Over the past six years, Papa has been instrumental in lowering the company's sky-high debt and keeping it out of bankruptcy court. Bausch said in a statement Thursday evening that billionaire hedge fund manager John Paulson will fill the vacant board position.

  • TVLine Items: SEAL Team Adds Series Regular, Outer Banks Casting and More

    SEAL Team is expanding its ranks, adding Raffi Barsoumian (Legends of Tomorrow) as a new series regular for Season 6 of the Paramount+ drama. The actor will play Omar, “a Senior Chief with 15 years of experience as a SEAL,” our sister site Deadline reports. “The son of Syrian immigrants, Omar has a deep understanding […]

  • Peloton and 2 other major ‘zombie’ companies could soon go to $0, leading stock research firm CEO says

    “Time is running out for cash-burning companies kept afloat with easy access to capital,” New Constructs CEO David Trainer said in a Thursday research note.

  • Here’s why Warren Buffett bought all the Occidental Petroleum shares he could, even with oil prices well above $100

    Energy prices are high. But bargain-hunter Buffett continues to bet on big oil.

  • 3 High-Yield Dividend Stocks That Could Soar

    High-yield dividend stocks are a major component of my stock portfolio. Here are three income stocks that have room for solid gains in the next year and even better gains over the long run. The blue-chip business development company (BDC) Main Street Capital (NYSE: MAIN) has held up better than the S&P 500 index, which is down 21% so far this year.

  • Will Alphabet Soar After Its Stock Split? Here's What History Shows

    The days of Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) stock trading above $2,000 are numbered. Investors often eagerly anticipate stock splits because they think shares could take off after the split. Let's first address the significance (or lack thereof) of stock splits.

  • JPMorgan’s Kolanovic Sees a 7% Boost for Stocks From Rebalancing

    (Bloomberg) -- JPMorgan Chase & Co.’s Marko Kolanovic, a steadfast bull on US equities during this year’s selloff, is calling for stocks to rise 7% next week as pension and sovereign wealth funds rebalance their portfolios.Most Read from BloombergSupreme Court Overturns Roe, Transforming Abortion-Rights FightStocks Roar Back With Best Week in a Month: Markets WrapJuul’s Vaping Products Are Ordered Off the Market in the USJustice Kavanaugh Says States May Not Bar Travel to Obtain an AbortionProte

  • You're One Step Closer to Being Able to Delay Your RMDs in Retirement

    A bill is headed for consideration by the full Senate that would move the age at which you have to start drawing down your retirement plan savings to 75. The House of Representatives passed a similar measure, so sponsors are … Continue reading → The post You're One Step Closer to Being Able to Delay Your RMDs in Retirement appeared first on SmartAsset Blog.

  • Twitter gives Elon Musk even more user data after billionaire complains about bots

    Mr Musk now has access to real-time data that could be the last hurdle ahead of his buyout

  • Banks rally after stress test, Bank of America underperforms

    Shares in the biggest U.S. banks rallied on Friday after they passed the Federal Reserve's annual health check, but Bank of America underperformed with test results implying it needs a larger-than-expected capital buffer, which could limit share buybacks and dividends. While the broader equity market also rallied on Friday, Wells Fargo & Co, up 7.5%, was the biggest gainer among the 34 lenders that underwent the Fed's so-called stress test, which measures how they would fare in a hypothetical severe economic downturn. The group would have roughly twice the capital required under Fed rules in the downturn scenario, it said.

  • Dow Jones Gains; Tesla Falls After Elon Musk Reveals These Fears; This Stock Up As Warren Buffett Raises Stake

    The Dow Jones moved higher as yields fell. Tesla stock skidded after CEO Elon Musk voiced a warning. A Warren Buffett stock rose.

  • This Is No Bitcoin Crash, It's A 'Crypto Ice Age' — And Here's Why

    Bitcoin bear markets aren't unusual. But cryptocurrencies have never faced such an aggressive Federal Reserve. Welcome to the crypto ice age.

  • Polestar Shares Rise in Electric-Vehicle Maker’s Market Debut

    Shares in Polestar Automotive Holding UK PLC jumped 16% on their first day of trading Friday, after the Swedish electric-vehicle maker completed a merger with a special-purpose acquisition company amid plans to expand globally. Polestar agreed to be acquired by blank-check company Gores Guggenheim in September. The auto maker is a unit of Volvo Car AB, which in turn is owned by Zhejiang Geely Holding Group Co. of China.